2,599
Views
10
CrossRef citations to date
0
Altmetric
Research paper

ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy

Running title: Role of ADAMTS-13 and ferroptosis in AKI.

, , , , &
Pages 11610-11621 | Received 16 Sep 2021, Accepted 13 Oct 2021, Published online: 07 Dec 2021

References

  • Liu KD, Goldstein SL, Vijayan A, et al. AKI!now initiative: recommendations for awareness, recognition, and management of AKI. Clin J Am Soc Nephrol. 2020;15(12):1838–1847. PubMed PMID: 32317329; PubMed Central PMCID: PMCPMC7769012.
  • Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66–ITC80. PubMed PMID: 29114754.
  • Crona DJ, Faso A, Nishijima TF, et al. A systematic review of strategies to prevent cisplatin-induced nephrotoxicity. Oncologist. 2017;22(5):609–619. PubMed PMID: 28438887; PubMed Central PMCID: PMCPMC5423518.
  • Potocnjak I, Broznic D, Kindl M, et al. Stevia and stevioside protect against cisplatin nephrotoxicity through inhibition of ERK1/2, STAT3, and NF-kappaB activation. Food Chem Toxicol. 2017;107(Pt A):215–225. PubMed PMID: 28666887.
  • Masias C, Cataland SR. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood. 2018;132(9):903–910. PubMed PMID: 30006329.
  • Kobayashi T, Wada H, Kamikura Y, et al. Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura. Thromb Res. 2007;119(4):447–452. PubMed PMID: 16797677.
  • Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-associated multiple organ failure and acute kidney injury. Crit Care Clin. 2015;31(4):661–674. PubMed PMID: 26410136; PubMed Central PMCID: PMCPMC5281060.
  • Tan Y, Luan ZQ, Hao JB, et al. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China. Lupus. 2018;27(3):389–398. PubMed PMID: 28786769.
  • Jamale TE, Hase NK, Kulkarni M, et al. Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury. Indian J Nephrol. 2012;22(4):298–300. PubMed PMID: 23162276; PubMed Central PMCID: PMCPMC3495354.
  • Zhou S, Jiang S, Guo J, et al. ADAMTS13 protects mice against renal ischemia-reperfusion injury by reducing inflammation and improving endothelial function. Am J Physiol Renal Physiol. 2019;316(1):F134–F45. PubMed PMID: 30461292.
  • Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. PubMed PMID: 32015325; PubMed Central PMCID: PMCPMC6997353.
  • Shu J, Hu Y, Yu X, et al. Elevated serum iron level is a predictor of prognosis in ICU patients with acute kidney injury. BMC Nephrol. 2020;21(1):303. PubMed PMID: 32711469; PubMed Central PMCID: PMCPMC7382811.
  • Hu Z, Zhang H, Yi B, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11(1):73. PubMed PMID: 31996668; PubMed Central PMCID: PMCPMC6989512.
  • Mishima E, Sato E, Ito J, et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J Am Soc Nephrol. 2020;31(2):280–296. PubMed PMID: 31767624; PubMed Central PMCID: PMCPMC7003311.
  • Zhou S, Guo J, Zhao L, et al. ADAMTS13 inhibits oxidative stress and ameliorates progressive chronic kidney disease following ischaemia/reperfusion injury. Acta Physiol (Oxf). 2021;231(3):e13586. PubMed PMID: 33226724.
  • Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84(6):1090–1095. PubMed PMID: 23783243.
  • Li W, Yang Y, Li Y, et al. Sirt5 attenuates cisplatin-induced acute kidney injury through regulation of Nrf2/HO-1 and Bcl-2. Biomed Res Int. 2019;2019:4745132. PubMed PMID: 31815138; PubMed Central PMCID: PMCPMC6878818.
  • Yang Y, Cai F, Zhou N, et al. Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2. Clin Transl Med. 2021;11(4):e382. PubMed PMID: 33931960; PubMed Central PMCID: PMCPMC8087913.
  • Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184. PubMed PMID: 26403645; PubMed Central PMCID: PMCPMC4688087.
  • Fan Z, Wirth AK, Chen D, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6(8):e371. PubMed PMID: 28805788; PubMed Central PMCID: PMCPMC5608917.
  • Hamed AA, Darwish YW, El-Sayed MH. ADAMTS13 levels in young patients with beta-thalassemia major: relation to Hepatitis C Virus infection, liver cirrhosis, and iron overload. Clin Appl Thromb Hemost. 2015;21(6):527–532. PubMed PMID: 25430937.
  • Wang S, Tang S, Chen X, et al. Pulchinenoside B4 exerts the protective effects against cisplatin-induced nephrotoxicity through NF-kappaB and MAPK mediated apoptosis signaling pathways in mice. Chem Biol Interact. 2020;331:109233. PubMed PMID: 32991863.
  • Sen Z, Jie M, Jingzhi Y, et al. Total coumarins from hydrangea paniculata protect against cisplatin-induced acute kidney damage in mice by suppressing renal inflammation and apoptosis. Evid Based Complement Alternat Med. 2017;2017:5350161. PubMed PMID: 28367225; PubMed Central PMCID: PMCPMC5358452.
  • Zheng D, Tao M, Liang X, et al. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway. Histol Histopathol. 2020;35(4):405–415. PubMed PMID: 31650524.
  • Cen WJ, Feng Y, Li SS, et al. Iron overload induces G1 phase arrest and autophagy in murine preosteoblast cells. J Cell Physiol. 2018;233(9):6779–6789. PubMed PMID: 29244196.
  • Holditch SJ, Brown CN, Lombardi AM, et al. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci. 2019;20(12). DOI:10.3390/ijms20123011. PubMed PMID: 31226747; PubMed Central PMCID: PMCPMC6627318.
  • Ono S, Matsui H, Noda M, et al. Functional regulation of von willebrand factor ameliorates acute ischemia-reperfusion kidney injury in mice. Sci Rep. 2019;9(1):14453. PubMed PMID: 31594992; PubMed Central PMCID: PMCPMC6783422.
  • Zarjou A, Bolisetty S, Joseph R, et al. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest. 2013;123(10):4423–4434. PubMed PMID: 24018561; PubMed Central PMCID: PMCPMC3784534.
  • Hao Y, Miao J, Liu W, et al. Formononetin protects against cisplatininduced acute kidney injury through activation of the PPARalpha/Nrf2/HO1/NQO1 pathway. Int J Mol Med. 2021;47(2):511–522. PubMed PMID: 33416097; PubMed Central PMCID: PMCPMC7797437.
  • Song W, Yin W, Ding L, et al. Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF-kappaB pathway and activation of Nrf2/ARE pathway in rats. Int Urol Nephrol. 2020;52(7):1389–1401. PubMed PMID: 32418008.
  • Dong H, Qiang Z, Chai D, et al. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging (Albany NY). 2020;12(13):12943–12959. PubMed PMID: 32601262; PubMed Central PMCID: PMCPMC7377827.
  • Liu P, Feng Y, Li H, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett. 2020;25(1):10. PubMed PMID: 32161620; PubMed Central PMCID: PMCPMC7045739.
  • Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016;41(3):274–286. PubMed PMID: 26725301; PubMed Central PMCID: PMCPMC4783254.
  • Robello E, Galatro A, Puntarulo S. Labile iron pool and ferritin content in developing rat brain gamma-irradiated in utero. Neurotoxicology. 2009;30(3):430–435. PubMed PMID: 19442828.